RIBAMIN Trademark

Trademark Overview

On Tuesday, January 5, 2021, a trademark application was filed for RIBAMIN with the United States Patent and Trademark Office. The USPTO has given the RIBAMIN trademark a serial number of 90448411. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, October 1, 2025. The RIBAMIN trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals; Pharmaceutical preparations, namely, antivirals
ribamin

General Information

Serial Number90448411
Word MarkRIBAMIN
Filing DateTuesday, January 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, October 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements

Goods and ServicesAntivirals; Pharmaceutical preparations, namely, antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressBeverly Hills, CA 90211
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBeverly Hills, CA 90211

Trademark Events

Event DateEvent Description
Friday, January 8, 2021NEW APPLICATION ENTERED
Saturday, April 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 14, 2021ASSIGNED TO EXAMINER
Wednesday, July 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, September 20, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, October 28, 2022TTAB RELEASE CASE TO TRADEMARKS
Thursday, December 16, 2021OPPOSITION INSTITUTED NO. 999999
Friday, October 28, 2022OPPOSITION TERMINATED NO. 999999
Friday, October 28, 2022OPPOSITION DISMISSED NO. 999999
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023SOU EXTENSION 1 FILED
Tuesday, June 13, 2023SOU EXTENSION 1 GRANTED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 2 FILED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 2 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 1, 2025ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 1, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 14, 2024SOU EXTENSION 3 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 14, 2024SOU EXTENSION 3 FILED

Related Keywords

ribamin antivirals namely pharmaceutical preparations